CD276 anticorps (AA 7-3, AA 100-300)
Aperçu rapide pour CD276 anticorps (AA 7-3, AA 100-300) (ABIN7876485)
Antigène
Voir toutes CD276 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 7-3, AA 100-300
-
Fonction
- B7-H3 Antibody / CD276
-
Purification
- Protein A/G affinity
-
Immunogène
- A portion of amino acids 100-300 from the human CD276 protein was used as the immunogen for the B7-H3 antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the B7-H3 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the B7-H3 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- CD276
-
Autre désignation
- B7-H3
-
Sujet
- T cell activation and immune function are regulated by the innate immune system through positive and negative costimulatory molecules. One such molecule, B7-H3 (B7-homolog 3, also designated B7RP-2 and CD276) belongs to the B7 immunoglobulin superfamily. Soluble B7-H3 binds a putative receptor on activated T-cells that is distinct from CD28, CTLA-4, ICOS and PD-1. Widely expressed on nonlymphoid tissues, B7-H3 costimulates proliferation of both CD4+ and CD8+ T cells. The ability of B7-H3 to stimulate Th1 and cytotoxic-T cell responses suggest that it may have antitumor activity. B7-H3 interactions may play a role in regulating cell-mediated immune responses against cancer, implicating B7-H3 as a potential therapeutic tool.
-
UniProt
- Q5ZPR3
-
Pathways
- Cancer Immune Checkpoints
Antigène
-